Long-term outcomes after peri-implantitis treatment and their influencing factors: a retrospective study

2022 ◽  
Vol 52 ◽  
Author(s):  
Sung-Bae Lee ◽  
Bo-Ah Lee ◽  
Seong-Ho Choi ◽  
Young-Taek Kim
2021 ◽  
Vol 93 (6) ◽  
pp. AB86
Author(s):  
Hirohito Tanaka ◽  
Shiko Kuribayashi ◽  
Masanori Sekiguchi ◽  
Atsuo Iwamoto ◽  
Yoko Hachisu ◽  
...  

2010 ◽  
Vol 42 (10) ◽  
pp. 4311-4313 ◽  
Author(s):  
M. Cherif ◽  
M. Ounissi ◽  
C. Karoui ◽  
K. Boubaker ◽  
I. Helal ◽  
...  

Author(s):  
Tianyun Xu ◽  
Fei Sun ◽  
Yanfang Li

<b><i>Objective:</i></b> The aim of this study was to evaluate the long-term outcomes and the factors related to patient prognosis. <b><i>Materials and Methods:</i></b> We retrospectively analyzed patients treated at the Department of Gynecology, Sun Yat-sen University Cancer Center, between January 1, 1968, and December 12, 2018. <b><i>Results:</i></b> A total of 107 patients were identified. Of all patients, 79 (73.8%) presented with stage I disease, 14 (13.1%) stage II, 13 (12.2%) stage III, and 1 (0.9%) stage IV. All patients received surgery, with 70 (65.4%) undergoing fertility-sparing surgery (FS) and 37 (34.6%) nonfertility-sparing surgery (NFS). Ninety patients received postoperative chemotherapy. Nine of the 43 cases with a lymphadenectomy had metastasis (20.9%). The median follow-up time was 132 months (range, 1–536 months). The overall 5-year and 10-year survival was 95.1% and 91.7%, respectively. The 10-year survival rate for stage I and II–IV patients was 96.1% and 79.1%, respectively (<i>p</i> = 0.008). For the patients undergoing FS and NFS, the 10-year disease-free survival rate was 82.3% and 88.0%, respectively (<i>p</i> = 0.403). The 10-year disease-free survival rate for patients with or without lymphadenectomy was 95.1% and 78.4%, respectively (<i>p</i> = 0.040), and it was 92.5% and 76.0%, respectively (<i>p</i> = 0.041), for those with or without omentectomy. Fifteen patients relapsed, and 4 of them (26.7%) had recurrence in the lymph nodes. Eleven of the 15 relapsed patients (73.3%) had been successfully salvaged. <b><i>Limitations:</i></b> As a study of a rare disease, our analysis was limited by its small sample size and the deemed disadvantage of a retrospective study. <b><i>Conclusion:</i></b> Excellent treatment results can be achieved in dysgerminoma patients who received proper treatment. Lymphadenectomy may improve patient survival. Relapsed patients can also be successfully salvaged.


2020 ◽  
Vol 6 (1) ◽  
pp. 107-117
Author(s):  
Russell Frood ◽  
Shishir Karthik ◽  
Saeed Mirsadraee ◽  
Ian Clifton ◽  
Karen Flood ◽  
...  

2017 ◽  
Vol 29 (1) ◽  
pp. 76-81 ◽  
Author(s):  
Jun-Yu Shi ◽  
Feng-Yuan Xu ◽  
Long-Fei Zhuang ◽  
Ying-Xin Gu ◽  
Shi-Chong Qiao ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document